WMSA
HZNP

Weiss Multi-Strategy Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-126,117
Closed -$13M – 787
2023
Q2 		$13M Sell
126,117
-2,147
-2% -$227K 0.26% 100
2023
Q1 		$14M Sell
128,264
-5,073
-4% -$561K 0.33% 91
2022
Q4 		$15.2M Buy
133,337
+92,410
+226% +$7.68M 0.43% 57
2022
Q3 		$2.53M Buy
40,927
+24,312
+146% +$1.7M 0.07% 359
2022
Q2 		$1.32M Sell
16,615
-37,794
-69% -$3.58M 0.04% 454
2022
Q1 		$5.72M Buy
54,409
+12,591
+30% +$1.23M 0.13% 248
2021
Q4 		$4.51M Buy
41,818
+1,699
+4% +$185K 0.1% 262
2021
Q3 		$4.39M Sell
40,119
-1,064
-3% -$110K 0.09% 275
2021
Q2 		$3.86M Buy
41,183
+1,471
+4% +$135K 0.08% 310
2021
Q1 		$3.65M Sell
39,712
-3,288
-8% -$277K 0.08% 314
2020
Q4 		$3.15M Buy
43,000
+7,000
+19% +$520K 0.06% 342
2020
Q3 		$2.8M Buy
36,000
+25,000
+227% +$1.72M 0.07% 301
2020
Q2 		$611K Buy
11,000
+1,561
+17% +$66.8K 0.02% 454
2020
Q1 		$280K Sell
9,439
-8,561
-48% -$290K 0.01% 374
2019
Q4 		$652K Buy
18,000
+1,000
+6% +$30.7K 0.01% 526
2019
Q3 		$463K Hold
17,000
– – 0.01% 499
2019
Q2 		$409K Buy
+17,000
New +$431K 0.01% 436

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Weiss Multi-Strategy Advisers's HZNP Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 126,117 shares — an estimated $13M sold.

Weiss Multi-Strategy Advisers first reported a position in HZNP in Q2 2019 and held it in 17 quarters. The position peaked at $15.2M in Q4 2022. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 126,117 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $13M.
  • Weiss Multi-Strategy Advisers first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 17 quarters.
  • Weiss Multi-Strategy Advisers's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $15.2M in Q4 2022.
  • 485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.